An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Insmed Incorporated
Related studies linked through entity extraction aliases.
A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Brensocatib in Participants With Normal Hepatic Function and Participants With Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis Bronchiectasis
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Brensocatib Tablets in Adults With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
- Status
- COMPLETED
- Phase
- PHASE3
Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase
- Status
- COMPLETED
- Phase
- PHASE2
Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis
- Status
- COMPLETED
- Phase
- PHASE2
Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease
- Status
- COMPLETED
- Phase
- PHASE2
Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone
- Status
- COMPLETED
- Phase
- PHASE3
Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) Infection
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa
- Status
- WITHDRAWN
- Phase
- PHASE3
Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections
- Status
- COMPLETED
- Phase
- PHASE3